The global hysteroscope market size is expected to reach USD 349.6 million by 2030, registering a CAGR of 5.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of infertility is expected to drive growth during the forecast period. Moreover, rising development of multifunctional hysteroscopes may boost the market. For instance, in August 2018, FDA approved UVision360’s Luminelle DTx Hysteroscopy System, which is designed to perform hysteroscopy and cystoscopy.
Hysteroscopy is a safe, quick, & widely used diagnostic and operative procedure for the treatment of abnormal uterine bleeding, fibroids, polyps, & other gynecological conditions. Manufacturers offer hysteroscopy kits that include a tubing set, video camera, alcohol prep pads, needle, syringe, swab, gloves, and tray.
The market is majorly driven by increasing R&D, resulting in rise in indications for hysteroscopy and its appropriate applications. According to a study published in August 2019, several hysteroscopic morphological features in endometrial cancer patients have been reported such as irregular surfaces, atypical vessels, various tumor growth patterns, & necrosis, which are papillary and polypoid. It was observed that hysteroscopic appearance can differentiate atypical endometrial hyperplasia from low-grade cancer, which may be helpful in the assessment of surgical strategies.
Request a free sample copy or view report summary: Hysteroscope Market Report
Based on the type, rigid hysteroscope market dominated the share in 2023 and is expected to witness significant growth over the forecast period
Rigid hysteroscope is widely used in both diagnosis and operative hysteroscopic procedures, whereas flexible ones are only used in diagnostic procedures.
Growth in rigid hysteroscope segment can be attributed to introduction of devices with advanced optic technology and enhanced image quality. Moreover, rigid hysteroscopes are more versatile than flexible hysteroscopes and are in high demand in healthcare settings.
Rigid hysteroscope is expected to witness lucrative growth due to rise in the number of gynecological procedures
Based on application, myomectomy dominated the market in 2023 in terms of revenue share
North America dominated the share in 2023 owing to rise in government initiatives to improve patient access to outpatient rehabilitation.
Grand View Research has segmented the global hysteroscope market based on product, application, end use, and region:
Hysteroscope Product Outlook (Revenue, USD Million, 2018 - 2030)
Rigid Hysteroscope
Flexible Hysteroscope
Disposable Hysteroscope
Hysteroscope Application Outlook (Revenue, USD Million, 2018 - 2030)
Myomectomy
Polypectomy
Endometrial Ablation
Others
Hysteroscope End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Hysteroscope Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players in the Hysteroscope Market
Olympus (Olympus Corporation)
Stryker
Karl Storz SE & Co. KG
Boston Scientific Corporation
Richard Wolf GmbH
Medtronic
B. Braun SE
Hologic, Inc.
CooperSurgical Inc.
Cook Medical
"The quality of research they have done for us has been excellent..."